Author: Zajicek John P.
Publisher: Adis International
ISSN: 1172-7047
Source: CNS Drugs, Vol.25, Iss.3, 2011-03, pp. : 187-201
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The use of cannabinoids in multiple sclerosis
Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. :
Cannabinoids in Multiple Sclerosis: Do They Have a Therapeutic Role?
By Killestein J. Uitdehaag B.M.J. Polman C.H.
Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. :
The safety of cannabinoids for the treatment of multiple sclerosis
By Smith Paul F
Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. :
Prescribing Cannabinoids for Multiple Sclerosis: Current Issues
By Pertwee R.G.
CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. :